AMO-02

AssetSmall molecule

Inhibition of glycogen synthase kinase 3 beta (GSK3B).

Stage
Phase 3
Modality
Small molecule
Target
GSK3B
Indications
1
Trials
0
Developers
1

Indications

1
  • Targets and what it contains1
  • Owner and partners3
  • Evidence for its targets1
  • Signals2

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Updated 7 Oct 2026 · 2 sources

Assets